wellrank.ai
Sign In
Mochi Health logo

Mochi Health

joinmochi.com

Obesity medicine telehealth clinic with board certified specialists.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Mochi Health, through Jul 29, 2026.

10.4%

Avg position when mentioned: 3.6 · peak 18% on Jul 19

By engine

Where Mochi Health is strong, and where it is invisible.

  • Claude
    16.7%
  • Perplexity
    16.7%
  • Google AI
    8.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 64 positive mentions
  • 42 neutral
  • 6 mixed or cautious

Recent AI answers mentioning Mochi Health

PerplexityJul 29, 2026, 09:44 UTC
My compounded semaglutide provider shut down. Where should I move my treatment?

If your compounded semaglutide provider shut down, the safest next step is to move only to a provider that uses a licensed U.S. compounding pharmacy and offers ongoing clinician oversight.[1][2][7] If you want the broadest “move fast” option, telehealth clinics with nationwide shipping are the easiest transition; if you want hands-on care, use a local weight-loss clinic or compounding pharmacy in your state.[1][3][7][8] A practical shortlist from the results: Mochi Health — appears in a 2026 rankings list as a lower-cost option with telehealth access, injectable/oral options, and nationwide availability noted in the listing.[15] Strut Health — listed as using LegitScript + ACHC-accredited compounded semaglutide and shipping to 49 states.[7] FitRx — listed as offering both brand-name GLP-1s and compounded semaglutide, with insurance coordination and availability in all 50 states + DC.[7] Rivas Weight Loss — a good choice if you’re in Maryland or Virginia and want in-person clinic visits with dose guidance.[2] Medi-Weightloss — useful if you want a local clinic model; the results show a Chandler, AZ location with weight-loss services.[6] Venice Apothecary and Marco Drugs & Compounding — examples of local compounding pharmacies that mention semaglutide compounding and prescription-based access.[8][9] A few important points before switching: Compounded semaglutide is still a pharmacy/legal question, not just a pricing question. One result cites FDA guidance saying compounded semaglutide remains legal through 503A pharmacies for patients with documented medical need, with limits on dispensing frequency; 503B facilities cannot currently compound it.[15] Because of that, you should verify the new pharmacy is licensed and check whether the clinic is working with a named, legitimate compounding pharmacy.[15] If your current dose is stable, ask the new clinician to match your existing titration schedule rather than restarting from scratch, unless they specifically recommend it for safety. This is a clinical inference based on standard GLP-1 care, not something directly stated in the search results. If you want the most reliable path, I’d prioritize: Your original prescriber’s replacement network, if any A telehealth clinic with a named licensed pharmacy A local obesity/weight-loss clinic with semaglutide experience If you tell me your state or ZIP code, I can narrow this to the best move-over options near you and separate telehealth vs local clinic vs pharmacy pickup.

Mentioned in position 1 of 7

Read full answer with sources →
PerplexityJul 28, 2026, 09:40 UTC
What are the most reputable compounded GLP-1 programs right now?

The most reputable compounded GLP-1 programs right now appear to be the ones that emphasize transparent pricing, licensed clinician oversight, and use of accredited/credentialed pharmacies. Based on the available rankings, the strongest names to look at are FormBlends, Eden, ShedRx, Trimi, Mochi Health, Henry Meds, and Ro.[3][4][1] Best options by reputation signal FormBlends — ranked highest in one review because it scored best on third-party testing, pharmacy credentials, transparent pricing, and no FDA warnings.[3] Eden — consistently placed near the top for safety/transparency and was rated highly in multiple rankings.[3][2] ShedRx — stood out for flat pricing, multiple formats, and a strong safety score in one 2026 ranking.[3] Trimi — praised for named 503A pharmacy partners, clinician-guided care, and all-in pricing.[4] Mochi Health — widely listed among top programs and noted for LegitScript certification in one ranking.[3][1] Henry Meds — frequently appears in top lists and is a large, established telehealth brand, though one source flags a weak BBB rating.[1][3] Ro — a major telehealth brand with its own pharmacy infrastructure, which helps with consistency and oversight.[4] How I’d interpret the market If you want the best reputation for safety/transparency, the strongest signals in the sources point to FormBlends, Eden, and ShedRx.[3] If you want a larger, more established consumer brand, Ro, Hims & Hers, and Henry Meds are the most recognizable names in the lists.[1][4] If you want the most cautious choice, several rankings stress picking programs that use accredited 503A pharmacies, publish batch testing/COAs, and avoid vague sourcing claims.[3][4] Programs I’d be more careful about Any provider with an F BBB rating or unclear sourcing deserves extra scrutiny; one ranking specifically noted Henry Meds carries an F BBB rating despite being included for transparency.[3] Rankings that are based mostly on editorial scoring can conflict, so reputation should be judged by pharmacy quality, clinician oversight, and transparency, not just placement on a list.[1][2][3][4] If you want, I can turn this into a shortlist by budget like “best overall,” “best low-cost,” and “best safest pick.”

Mentioned in position 5 of 8

Read full answer with sources →
ClaudeJul 28, 2026, 09:40 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

Compounded GLP-1 Providers Using Licensed US Pharmacies Here are some well-known providers that work with FDA-registered, state-licensed 503B or 503A compounding pharmacies in the US: Telehealth + Pharmacy Partners Hims & Hers – uses licensed compounding pharmacies; transparent about their pharmacy partners Ro (Body Program) – works with licensed 503B compounding pharmacies Noom Med – partners with licensed US compounding pharmacies LifeMD / Rex MD – uses licensed compounding partners Mochi Health – connects patients with licensed pharmacy networks Eden – works with 503A licensed compounding pharmacies Direct Pharmacy/Clinic Models Ivy Rx – operates its own licensed compounding pharmacy Beluga Health – uses licensed US compounding pharmacies Henry Meds – partners with licensed compounding pharmacies Important Caveats ✅ Look for 503B "outsourcing facilities" for the highest federal oversight ⚠️ The FDA has been phasing out compounded semaglutide as shortages resolve — availability may change Always verify the pharmacy's license directly (NABP database is helpful) Confirm the active ingredient is semaglutide, not just a "peptide blend" Would you like help comparing pricing or specific formulations?

Mentioned in position 6 of 10

Read full answer with sources →
PerplexityJul 26, 2026, 10:57 UTC
What are the best online GLP-1 weight loss programs in 2026?

The best online GLP-1 weight loss program in 2026 depends on what you value most: overall care quality, lowest price, or best insurance help. Based on the rankings and program features in the provided sources, Ro Body, Mochi Health, Henry Meds, Calibrate, and Found are the strongest names to consider.[2][3][5][7][10][11] If you want the shortest answer: Best overall: Ro Body for a polished, integrated experience with strong clinician support and pharmacy access.[3][6][10] Best for comprehensive coaching: Calibrate for structured, long-term metabolic coaching and obesity-medicine oversight.[1][7][11] Best for insurance navigation: Mochi Health for its insurance-focused workflow and integrated care.[2][4] Best for transparent cash-pay pricing: Henry Meds for straightforward monthly billing and competitive pricing.[2][4][10] Best budget-friendly marketplace model: Sesame if you want to compare providers and avoid a large membership commitment.[3][7][10] A practical comparison of the top options: Program Best for Why it stands out Ro Body Best overall Broad access, integrated pharmacy, strong clinician support, and both insurance and cash-pay paths.[3][6][10] Calibrate Best coaching Full metabolic-health program with obesity specialists, labs, and structured behavior coaching.[1][7][11] Mochi Health Insurance help Strong insurance-navigation focus and bundled care.[2][4] Henry Meds Cash-pay simplicity Clear monthly pricing and clinician follow-up.[2][4][10] Found Flexible weight-loss support Coaching plus GLP-1 and non-GLP-1 options.[3][10] Sesame Value/choice Marketplace model can reduce consultation costs.[3][7][10] Hims & Hers Convenience and brand familiarity Large platform with broad telehealth access.[2][10] A few useful details from the sources: Ro Body is repeatedly described as a top-rated or top-ranked option because it combines medication access, clinician support, and an integrated pharmacy model.[3][6][10] Calibrate is positioned as the most comprehensive program, with board-certified obesity-medicine specialists, lab work, and structured coaching across lifestyle areas.[1][7][11] Mochi Health is highlighted for insurance navigation and comprehensive care.[4] Henry Meds is often recommended when price transparency matters most.[2][4][10] Some guides also mention manufacturer-direct programs such as LillyDirect and NovoCare as important options for brand-name access, especially when you want direct self-pay pathways.[7][9] If you want the best choice by use case, I’d narrow it this way: Most people: Ro Body[3][6] Best hands-on support: Calibrate[1][7][11] Best to try insurance coverage first: Mochi Health[2][4] Best if you want low-friction cash pay: Henry Meds[2][4][10] Best if you want to compare doctors and prices: Sesame[3][7][10] If you want, I can also give you a 2026 ranked list by price, by insurance coverage, or by best programs for Wegovy vs. Zepbound.

Mentioned in position 2 of 9

Read full answer with sources →
Google AIJul 25, 2026, 12:37 UTC
Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

The landscape for compounded GLP-1s has become significantly more complex after the FDA crackdown, which primarily targeted companies using unapproved ingredients (like semaglutide salts) or misrepresenting their products. The key for any service legally offering compounded GLP-1s is adherence to very specific FDA guidelines: Brand Name Shortage: Compounding is generally only permissible when there is an official shortage of the FDA-approved brand-name drug (e.g., Ozempic, Wegovy, Zepbound, Mounjaro). The FDA maintains a drug shortage list. FDA-Registered API Source: The active pharmaceutical ingredient (API) must come from an FDA-registered manufacturing facility. Licensed Compounding Pharmacy: The compounding must be done by a licensed compounding pharmacy, specifically for an individual patient based on a valid prescription from a licensed medical professional. No Semaglutide Salts: The FDA has explicitly warned against compounded drugs containing semaglutide salts (like semaglutide sodium or semaglutide acetate), as these are not the same active ingredient as in approved drugs and their safety/efficacy are unknown. Given these stringent requirements, many services have either stopped offering compounded versions or have adjusted their practices to ensure strict compliance. Here are some telehealth services that may still offer compounded GLP-1s (typically compounded semaglutide or tirzepatide with vitamin B12) under the current regulatory environment, often by partnering with specific compounding pharmacies. It's crucial to always do your own due diligence and ask specific questions about their practices: Henry Meds: Why: They explicitly market and offer compounded GLP-1 options. They typically state they partner with licensed compounding pharmacies that source APIs from FDA-registered facilities. They aim for transparency regarding their pharmacy partners. What to Ask: Confirm their current pharmacy partners, the specific API source, and ensure they are providing the semaglutide base* and not a salt. Mochi Health: Why: Mochi is another telehealth provider focusing on weight management that often includes compounded GLP-1 options as part of their comprehensive programs. They also emphasize working with compliant pharmacies. What to Ask: Inquire about their compounding pharmacy partners, API sourcing, and the exact formulation of the compounded medication. Push Health / Alpha Medical (Platforms for Independent Providers): Why: These are platforms where independent licensed medical providers offer their services. While the platforms themselves don't directly "offer" compounded GLP-1s, you might find individual providers on these platforms who are willing to prescribe them, working with their own chosen compounding pharmacies. What to Ask: If using these platforms, it's vital to vet the individual provider and the specific compounding pharmacy* they use. Ask all the due diligence questions directly to the prescriber. What to Ask and Look For When Choosing a Service: Regardless of the service you choose, it is paramount to ask these questions to ensure safety and legality: Which compounding pharmacy do you partner with? (Look up the pharmacy's licensure and reviews). Where does the API (Active Pharmaceutical Ingredient) come from? (It should be from an FDA-registered facility). What is the exact formulation of the compounded medication? (Ensure it is semaglutide base*, not a salt like semaglutide sodium or acetate). How do you verify the current FDA drug shortage list? (This is the legal justification for compounding). What are the qualifications of the prescribing physician? Important Disclaimer: The regulatory landscape is constantly evolving. Always consult directly with the telehealth provider, ask detailed questions, and verify their practices to ensure they align with current FDA guidelines and your health needs. Compounded medications carry different risks than FDA-approved brand-name drugs.

Mentioned in position 2 of 4

Read full answer with sources →
ClaudeJul 25, 2026, 12:37 UTC
Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

This is a quickly evolving situation, so here's an honest breakdown: What Happened The FDA declared the semaglutide shortage over (early 2025), which restricts compounding pharmacies from making copies of brand-name GLP-1s like Ozempic/Wegovy. Services Still Navigating This Space Still offering some compounded options (as of early 2025): Hims & Hers - fought back publicly against FDA restrictions Ro - has been working with 503B compounders Henry Meds - focused on affordability Mochi Health - exploring alternatives Important Caveats Situations change weekly - lawsuits are ongoing Some are pivoting to tirzepatide (Mounjaro/Zepbound), whose shortage status differs 503B compounders (hospital-grade) have different rules than 503A My Honest Recommendation Check each service's current website directly - information from even weeks ago may be outdated Ask specifically whether they use 503A or 503B pharmacies Consider whether branded medications with coupons might now be competitive Would you like help thinking through brand-name affordability options instead? That landscape may actually be more stable right now.

Mentioned in position 4 of 4

Read full answer with sources →

TL;DR

Mochi Health is an obesity medicine telehealth clinic connecting patients with board-certified specialists for GLP-1 and weight management care. It operates at joinmochi.com and currently holds a WellRank AI visibility score of 13% in the Compounded GLP-1s category, ranking eighth in that topic, while appearing in the low single digits across broader GLP-1, Wegovy, and Ozempic query sets, suggesting strong niche recognition but room to grow in higher-volume searches.

Company Overview

Mochi Health operates as a direct-to-patient telehealth clinic focused specifically on obesity medicine, staffed by board-certified physicians who evaluate and treat patients seeking medical weight loss. Its business model centers on subscription or visit-based access to clinicians who can prescribe FDA-approved and compounded GLP-1 medications. The company positions itself as a clinical-grade alternative to general telehealth platforms by emphasizing specialty expertise in obesity care. Its headquarters and founding year are not publicly disclosed in widely verifiable sources.

Product Features

  • Board-certified obesity medicine specialist consultations via telehealth
  • Prescriptions for GLP-1 receptor agonists including semaglutide and tirzepatide
  • Access to compounded GLP-1 medications as a lower-cost pathway
  • Ongoing care coordination and medication management
  • Personalized treatment plans combining medication with lifestyle guidance

Target Market

Mochi Health serves adults in the United States seeking medically supervised weight loss, particularly those interested in GLP-1 therapies who may not have access through traditional insurance or primary care channels. It is relevant to patients with obesity or weight-related conditions who want specialty-level oversight rather than a general urgent-care telehealth visit.

Buyer Personas

  • A middle-aged adult with obesity who has struggled with diet-only approaches and wants a physician-supervised GLP-1 prescription without navigating in-person specialist waitlists.
  • A cost-conscious patient who has seen branded GLP-1 prices and is researching compounded semaglutide as an affordable alternative through a credentialed provider.
  • Someone who has already tried a general telehealth platform for weight loss and wants a clinic that specializes exclusively in obesity medicine.
  • A patient whose primary care doctor is unfamiliar with GLP-1 dosing protocols and who is seeking a dedicated obesity medicine telehealth team.

Funding & Performance

Funding stage, total capital raised, and valuation for Mochi Health are not publicly disclosed in widely verifiable sources.

Recent Developments

Mochi Health has been broadly noted in the telehealth weight loss space as interest in compounded GLP-1 medications has grown, and it appears in roundups covering affordable or accessible GLP-1 providers such as Forbes Health's list of best affordable online GLP-1 providers and U.S. News coverage of top GLP-1 weight loss medication providers. The company has continued to emphasize its obesity medicine specialization as a differentiator as regulatory scrutiny around compounded GLP-1s has increased industry-wide.

Competitive Landscape

According to WellRank co-mention data, AI engines most frequently name Mochi Health alongside Henry Meds, Ro, Hims and Hers, Calibrate, Push Health, Alpha Medical, WeightWatchers Clinic, and WeightWatchers. Platforms like GoodRx's GLP-1 online provider guide and Walgreens virtual weight loss resources also surface competing options in the same answer sets. Mochi's clearest point of differentiation in this field is its stated focus on board-certified obesity medicine specialists rather than general practitioners.

Mochi Health vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Mochi Health logo
Mochi HealthThis brand
#8
10.4%
Henry Meds logo
Henry Meds

59 shared answers

#5
12.5%
Ro logo
Ro

43 shared answers

#2
33.3%
Hims & Hers logo
Hims & Hers

38 shared answers

#1
33.3%
Calibrate logo
Calibrate

34 shared answers

#9
10.4%

Email me when overtakes Mochi Health

One email the day the ranks flip. Nothing else.

User Sentiment

Of the 75 AI engine mentions tracked by WellRank, 41 carry a positive tone, 28 are neutral, and only 6 are mixed or cautious, indicating a generally favorable AI-mediated reputation. Community discussion surfaces on platforms like Reddit's antidietglp1 community, where patients compare provider experiences in candid terms. The small proportion of cautious mentions likely reflects industry-wide concerns about compounded GLP-1 oversight rather than issues specific to Mochi Health.

Pricing

Mochi Health's specific subscription or visit fees are not published in a stable, widely verifiable form, so pricing varies and prospective patients should confirm current costs directly at joinmochi.com. General reporting positions it as a more affordable option relative to branded GLP-1 pathways, largely because of its compounded medication access.

Sources cited around Mochi Health

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Mochi Health weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Mochi Health? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.